Adamantane resistance in seasonal human influenza a viruses from Calgary, Alberta (January 2007 to August 2008)

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 21, Issue 2, 2010, Pages

  Pabbaraju, Kanti ^a   Wong, Sallene ^a   Kits, Dmitri K ^b   Fox, Julie D ^a,c  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adamantane; Amantadine; Antiviral; Influenza; M2 protein; Resistance

Indexed keywords

ADAMANTANE; ASPARAGINE; PROTEIN M2; SERINE;

ADOLESCENT; AGED; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIVIRAL RESISTANCE; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEASONAL VARIATION; VIRUS CULTURE; VIRUS ISOLATION; VIRUS MUTATION;

EID: 77953643549     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/710149     Document Type: Article

References (21)

1. Sheu TG, Deyde VM, Okomo-Adhiambo M, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 2008;52:3284-92.
2. Dawood S, Jain S, Finelli L, et al. Emergence of a novel swineorigin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15.
3. Wang C, Takeuchi K, Pinto LH, Lamb RA. Ion channel activity of influenza A virus M2 protein: Characterization of the amantadine block. J Virol 1993;67:5585-94. (Pubitemid 23241395)
4. Pielak RM, Schnell JR, Chou JJ. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc Natl Acad Sci 2009;106:7379-84.
5. Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol 1988;62:1508-12.
6. Hay AJ, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH. Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother 1986;18(Suppl B):19-29. (Pubitemid 17199048)
7. Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern. Lancet 2005;366:1175-81.
8. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006;295:891-4.
9. Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007;196:249-57. (Pubitemid 47047464)
10. Moore C, Hibbitts S, Owen N, et al. Development and evaluation of a realtime nucleic acid sequence based amplification assay for rapid detection of influenza A J Med Virol 2004;74:619-28.
11. Pabbaraju K, Ho KC, Wong S, et al. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007). Antiviral Res 2008;79:81-6.
12. Ziegler T, Hemphill ML, Ziegler ML, et al. Low incidence of rimantadine resistance in field isolates of influenza A viruses. J Infect Dis 1999;180:935-9. (Pubitemid 30070171)
13. Saito R, Li D, Suzuki H. Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006. N Engl J Med 2007;356:312-3.
14. Higgins RR, Eshaghi A, Burton L, Mazzulli T, Drews SJ. Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada. J Clin Virol 2009;44:91-3.
15. Update: Influenza activity - United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:369-74.
16. Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, Oshitani H. Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol 2009;47:841-4.
17. Barr IG, Hurt AC, Iannello P, Tomasov C, Deed N, Komadina N. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral Res 2007;73:112-7. (Pubitemid 46135769)
18. Simonsen L, Viboud C, Grenfell BT, et al. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 2007;24:1811-20. (Pubitemid 47236702)
19. Bean WJ, Threlkeld SC, Webster RG. Biologic potential of amantadine-resistant influenza A virus in an avian model. J Infect Dis 1989;159:1050-6.
20. Nelson MI, Simonsen L, Viboud C, Miller MA, Holmes EC. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology 2009;388:270-8.
21. Allen JE, Gardner SN, Vitalis EA, Slezak TR. Conserved amino acid markers from past influenza pandemic. BMC Microbiol 2009;9:77.